Cargando…
RETRACTED ARTICLE: Inter- and intraobserver agreement of the quantitative assessment of [(99m)Tc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer
PURPOSE: Checkpoint inhibition therapy using monoclonal antibodies against programmed cell death protein 1 (PD-1) or its ligand (PD-L1) is now standard management of non-small cell lung cancer (NSCLC). PD-L1 expression is a validated and approved prognostic and predictive biomarker for anti-PD-1/PD-...
Autores principales: | Hughes, Daniel Johnathan, Chand, Gitasha, Goh, Vicky, Cook, Gary J. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708592/ https://www.ncbi.nlm.nih.gov/pubmed/33259032 http://dx.doi.org/10.1186/s13550-020-00734-x |
Ejemplares similares
-
Retraction Note to: Inter- and intraobserver agreement of the quantitative assessment of [(99m)Tc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer
por: Hughes, Daniel Johnathan, et al.
Publicado: (2021) -
Inter-rater and intra-rater agreement of [(99m)Tc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer
por: Hughes, Daniel Johnathan, et al.
Publicado: (2023) -
[(99m)Tc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression
por: Nazir, Muhummad Sohaib, et al.
Publicado: (2023) -
SPECT/CT imaging of chemotherapy-induced tumor apoptosis using (99m)Tc-labeled dendrimer-entrapped gold nanoparticles
por: Xing, Yan, et al.
Publicado: (2018) -
Early Phase I Study of a (99m)Tc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung Cancer
por: Xing, Yan, et al.
Publicado: (2019)